KUHROVÁ, Viera, Hana FRANCOVÁ, Petra ZAPLETALOVÁ, Tomáš FREIBERGER, Lenka FAJKUSOVÁ, Eva HRABINCOVÁ, Romana SLOVÁČKOVÁ and Libor KOZÁK. Spectrum of low density lipoprotein receptor mutations in Czech hypercholesterolemic patients. Human Mutation. New York (NY): Wiley-Liss, Inc., 2001, vol. 18, No 3, 5 pp. ISSN 1059-7794.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Spectrum of low density lipoprotein receptor mutations in Czech hypercholesterolemic patients
Name in Czech Spektrum mutací v genu pro LDL receptor u českých pacientů s familiární hypercholesterolémií
Authors KUHROVÁ, Viera (203 Czech Republic, guarantor), Hana FRANCOVÁ (203 Czech Republic), Petra ZAPLETALOVÁ (203 Czech Republic), Tomáš FREIBERGER (203 Czech Republic), Lenka FAJKUSOVÁ (203 Czech Republic), Eva HRABINCOVÁ (203 Czech Republic), Romana SLOVÁČKOVÁ (203 Czech Republic) and Libor KOZÁK (203 Czech Republic).
Edition Human Mutation, New York (NY), Wiley-Liss, Inc. 2001, 1059-7794.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 6.134
RIV identification code RIV/00216224:14310/01:00004341
Organization unit Faculty of Science
Keywords in English familial hypercholesterolemia; FH; LDL receptor; LDLR; Czechoslovakian
Tags Czechoslovakian, familial hypercholesterolemia, FH, LDL receptor, LDLR
Changed by Changed by: prof. MUDr. Tomáš Freiberger, Ph.D., učo 24036. Changed: 14/7/2009 09:24.
Abstract
The aim of our study was to define mutations causing familial hypercholesterolemia (FH) phenotype in Czech hypercholesterolemic individuals. A combinations of heteroduplex analysis, SSCP, DGGE, DNA sequencing and PCR/restriction analysis was used for this purpose. Molecular searching in the promoter region and coding sequence of the low density lipoprotein receptor (LDLR) gene in 130 patients from 68 unrelated families resulted in the identification of 37 sequence variations. Thirty of them are most likely disease causing mutations. Nineteen mutations were novel (two nonsense, five missense, six nucleotide(s) insertions and six nucleotide(s)deletions). Their pathological effect can be predicted on the basis of their position with respect activity to previously reported mutations with an estimated reduction of the receptor activity and/or premature termination of translation. These results expand our knowledge of mutations responsible for FH. Seven nucleotide variations were characterized as silent polymorphism.
Abstract (in Czech)
V práci jsou charakterizovány mutace v genu pro LDL receptor v souboru 130 pacientů s familiární hypercholesterolémií z 68 českých nepříbuzných rodin.
Links
NE5554, research and development projectName: Molekulárně-genetická analýza hyperlipoproteinémií: Vliv mutací pro LDL receptor, apoB-100 a poE na fenotyp familiárních hypercholesterolémií
PrintDisplayed: 17/5/2024 23:29